The words "blood cancer" are not enough to choose a treatment. Doctors first need the exact type and subtype. They then look at how the disease is behaving, what the tests show, and what treatment is likely to be safe for that person.
So two people with blood cancer can receive very different treatment plans. One may need treatment quickly. Another may take a medicine chosen for a specific change found in the cancer cells. A slower-growing blood cancer may be monitored for a time.
Key takeaways • Blood cancer treatment is not the same for everyone. The exact type and subtype come first. • Treatment may include chemotherapy, tablets or other targeted medicines, immune-based treatments, radiotherapy, a stem-cell transplant or regular monitoring without immediate treatment. • Blood cancers are not all described in the same way. Some use stages, while others use different systems to describe how the disease is behaving or how much risk it carries. • Test results, overall health, previous treatment and the way the cancer responds can all change the plan. • Some blood cancers need prompt treatment, while selected slower-growing conditions may be monitored first. |
Main treatment options for blood cancer
There is no single blood cancer treatment. Depending on the diagnosis, doctors may use one approach or combine several.
Treatment approach | How it may fit into care |
Chemotherapy | Used in many acute leukaemias and lymphomas. The medicines, combinations and intensity vary by disease. |
Targeted treatment | Medicines chosen to act on a specific change found in the cancer cells. |
Immune-based treatments | Treatments that help the immune system recognise or attack cancer cells. |
CAR-T cell therapy | A specialist treatment in which some of a person's own immune cells are changed in a laboratory so they can recognise cancer cells. It is used only for some blood cancers and at certain points in treatment. |
Stem-cell transplantation | Gives blood-forming stem cells after treatment that prepares the body for the transplant. It is only suitable for some people. |
Radiotherapy | Uses radiation to treat a specific area. It may be used in some lymphomas or to help control symptoms. |
Active monitoring | Regular check-ups without starting treatment straight away. This is used for some slower-growing blood cancers. |
These are broad treatment types. Even when two people receive the same kind of treatment, the medicine, schedule and reason for using it may be different.
What doctors look at before choosing treatment
If you compare your treatment with someone else's, the plans may look surprisingly different. The diagnoses, disease features or health needs may not be the same. Those differences can change which options are suitable.
Your exact diagnosis comes first
Leukaemia, lymphoma and multiple myeloma are all blood cancers, but they are not treated as one disease.
Even within one group, the exact type matters. Acute myeloid leukaemia and chronic lymphocytic leukaemia, for example, are both leukaemias but can behave very differently and need different treatment.
Because leukaemia, lymphoma and multiple myeloma can follow different treatment pathways, it helps to understand how these blood cancers differ before comparing treatment options.
Stage is not used in the same way for every blood cancer
Stage is one way doctors describe how much cancer is present, but it is not used in the same way for every blood cancer.
Lymphomas often use stages. Some leukaemias are described in other ways, while myeloma and chronic lymphocytic leukaemia have their own systems. (NCI; American Cancer Society)
You do not need to remember the name of the system. Ask what it tells your doctor and whether it changes the treatment options.
Some test results can change which treatments are suitable
After diagnosis, some laboratory tests look more closely at the cancer cells.
In certain blood cancers, a test may find a specific change that can be targeted with a medicine. Other results may help doctors understand how the cancer is likely to behave or how closely it needs to be monitored. Not every result changes treatment. (NCI)
These tests can be part of what happens after a blood cancer diagnosis, when doctors confirm the subtype and decide what needs to happen next.
Treatment timing and your overall health matter too
Some blood cancers need treatment quickly
A blood cancer diagnosis does not always mean treatment starts immediately.
Some aggressive blood cancers need prompt treatment because they can progress quickly. Some slower-growing conditions may be monitored first.
For example, some people with slow-growing chronic lymphocytic leukaemia or lymphoma may have regular check-ups instead of starting treatment straight away. This is called active monitoring.
Active monitoring still involves regular appointments and tests. Treatment is started if there is a medical reason to begin it.
Age matters, but fitness matters too
A person's age can affect treatment decisions, but age on its own does not decide what someone can receive.
Two people of the same age can have very different health needs. Doctors look at how well the body is likely to handle treatment. Heart, kidney, liver or lung function may matter, along with mobility, other illnesses, medicines and nutrition.
Age is not used as a simple cut-off. Some older adults can tolerate intensive treatment, while a younger person with other health problems may need a different approach.
Previous treatment can change what comes next
Treatment used when a blood cancer is first diagnosed may be different from treatment used if it returns or stops responding.
If the cancer comes back after treatment, doctors look at what was used before, how well it worked and what side effects it caused. If the cancer did not respond well in the first place, a different treatment may be needed.
The plan can change after treatment starts
Doctors do not always know every step of a treatment plan on day one.
At certain points, the team checks how well treatment is working. This may involve blood tests, scans or, in some cases, another bone marrow test.
Some blood cancers also use very sensitive tests that can detect tiny amounts of cancer left after treatment. These tests are useful only in certain diseases. (NCI)
If the response is different from what the team expected, the next step may change. Side effects or new test results can also lead to an adjustment.
Chemotherapy is important, but it is not always used
Chemotherapy remains important for many blood cancers, including many acute leukaemias and lymphomas. But it is not the only way blood cancer can be treated.
Some blood cancers can be treated with tablets or other medicines that are chosen for specific features of the cancer. Others may be treated with medicines that work through the immune system. Some slower-growing blood cancers may be monitored for a time before treatment is needed. (NCI)
A treatment that does not use chemotherapy is not automatically safer or easier. Other cancer medicines can also cause important side effects and still need regular monitoring.
Supportive care may also be needed alongside cancer-directed treatment. This can include help with infections, low blood counts, treatment side effects, pain, nutrition or emotional wellbeing.
Complementary therapies should not be used in place of cancer-directed treatment. Herbal products and dietary supplements can interact with anticancer medicines, so discuss them with the treating team before using them. (NCI)
Before treatment starts, ask why this plan has been recommended
You do not need to remember every medical term. What matters is understanding why this plan has been recommended and what the team expects it to achieve.
These questions can help:
• What exact blood cancer and subtype do I have?
• How are you describing the extent or risk of my cancer, and does that affect treatment?
• Did any test result change which treatments are suitable for me?
• What is the goal of treatment in my situation?
• Why is this option being recommended, and what other options could be considered?
• How and when will we know whether it is working?
• What side effects or warning signs should I contact the team about?
Writing the answers down, or bringing someone who can take notes, can make a complicated appointment easier to follow.
If you have been offered a plan, ask which factors mattered most in your case. That is often more useful than comparing your treatment with someone else's.
If you already have a diagnosis
If you have been diagnosed with blood cancer and want to discuss supportive care alongside your oncology treatment, you can schedule a consultation with Dr Tarang Krishna. This does not replace care from your haematology or oncology team.
Read more from the blood cancer series
• What Is Blood Cancer? Early Signs, Symptoms and When to Get Checked
• Leukaemia, Lymphoma and Multiple Myeloma: What Is the Difference?
• Blood Cancer Diagnosis: Blood Tests, Bone Marrow Evaluation and What Happens Next
References
National Cancer Institute (2024) Chronic Lymphocytic Leukemia Treatment (PDQ®) – Patient Version. Updated 15 October 2024.
National Cancer Institute (2024) Cancer Therapy Interactions With Foods and Dietary Supplements (PDQ®) – Patient Version.
Blood Cancer UK (2024) Active Monitoring Explained.
American Cancer Society (2025) Hodgkin Lymphoma Stages. Last revised 6 October 2025.
